Pharmacology and Therapeutics
Showing page 2 of 8 pages of list content
-
The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19
This article's authors -
Assessment of Hydroxychloroquine and Chloroquine Safety Profiles â A Systematic Review and Meta-Analysis
This article's authors -
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
This article's authors -
A systematic review and meta-analysis to evaluate the clinical outcomes in COVID -19 patients on angiotensin converting enzyme inhibitors or angiotensin receptor blockers
This article's authors -
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs
This article's authors -
Review of Current Evidence of Hydroxychloroquine in Pharmacotherapy of COVID-19
This article's authors -
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics
This article's authors -
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19)
This article's authors -
Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials
This article's authors -
The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study
This article's authors